1
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Feng BJ, Huang W, Shugart YY, et al:
Genome-wide scan for familial nasopharyngeal carcinoma reveals
evidence of linkage to chromosome 4. Nat Genet. 31:395–399.
2002.PubMed/NCBI
|
4
|
Lee N, Xia P, Quivey JM, et al:
Intensity-modulated radiotherapy in the treatment of nasopharyngeal
carcinoma: an update of the UCSF experience. Int J Radiat Oncol
Biol Phys. 53:12–22. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yang GD, Huang TJ, Peng LX, et al:
Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote
the resistance of nasopharyngeal carcinoma cells to
cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L. PLoS
One. 8:e783552013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ruden M and Puri N: Novel anticancer
therapeutics targeting telomerase. Cancer Treat Rev. 39:444–456.
2013. View Article : Google Scholar
|
7
|
Ouellette MM, Wright WE and Shay JW:
Targeting telomerase-expressing cancer cells. J Cell Mol Med.
15:1433–1442. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ruden M and Puri N: Novel anticancer
therapeutics targeting telomerase. Cancer Treat Rev. 39:444–456.
2013. View Article : Google Scholar
|
9
|
Röth A, Harley CB and Baerlocher GM:
Imetelstat (GRN163L) - telomerase-based cancer therapy. Recent
Results Cancer Res. 184:221–234. 2010. View Article : Google Scholar
|
10
|
Shay JW and Keith WN: Targeting telomerase
for cancer therapeutics. Br J Cancer. 98:677–683. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Xu Q, Zhang Z, Zhang P and Chen W:
Antisense oligonucleotides and all-trans retinoic acid have a
synergistic anti-tumor effect on oral squamous cell carcinoma. BMC
Cancer. 8:1592008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Goldblatt EM, Gentry ER, Fox MJ, Gryaznov
SM, Shen C and Herbert BS: The telomerase template antagonist
GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits
growth, and augments the effects of paclitaxel. Mol Cancer Ther.
8:2027–2035. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Gomez-Millan J, Goldblatt EM, Gryaznov SM,
Mendonca MS and Herbert BS: Specific telomere dysfunction induced
by GRN163L increases radiation sensitivity in breast cancer cells.
Int J Radiat Oncol Biol Phys. 67:897–905. 2007. View Article : Google Scholar
|
14
|
Xu Z, Fang S, Zuo Y, et al: Combination of
pigment epithelium-derived factor with radiotherapy enhances the
antitumor effects on nasopharyngeal carcinoma by downregulating
vascular endothelial growth factor expression and angiogenesis.
Cancer Sci. 102:1789–1798. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Blackburn EH: Switching and signaling at
the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kyo S and Inoue M: Complex regulatory
mechanisms of telomerase activity in normal and cancer cells: how
can we apply them for cancer therapy? Oncogene. 21:688–697. 2002.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhang Y, Zhang H, Zhai Y, et al: A
functional tandem-repeats polymorphism in the downstream of TERT is
associated with the risk of nasopharyngeal carcinoma in Chinese
population. BMC Med. 9:1062011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang Y, Duan HG, Chen SM, Xiao BK, Cheng J
and Tao ZZ: Effect of RNA interference targeting human telomerase
reverse transcriptase on telomerase and its related protein
expression in nasopharyngeal carcinoma cells. J Laryngol Otol.
121:476–482. 2007. View Article : Google Scholar
|
19
|
Zhang SZ, Huang PC, Xu Y, Chen J and Cai
KR: Effects of telomerase sense and antisense oligodeoxynucleotides
on growth and differentiation of nasopharyngeal carcinoma cells. Ai
Zheng. 21:493–497. 2002.(In Chinese). PubMed/NCBI
|
20
|
Marian CO, Cho SK, McEllin BM, et al: The
telomerase antagonist, imetelstat, efficiently targets glioblastoma
tumor-initiating cells leading to decreased proliferation and tumor
growth. Clin Cancer Res. 16:154–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang X, Liu Y, Chow LS, et al: Regulation
of telomerase activity by gamma-radiation in nasopharyngeal
carcinoma cells. Anticancer Res. 20:433–437. 2000.PubMed/NCBI
|